An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Stopped Study was never initiated due to company decision. No study subjects were ever enrolled or dosed.

Conditions

• Acne Vulgaris

Interventions

• DRUG: Dapsone Formulation A
• DRUG: Dapsone Formulation B
• DRUG: Dapsone Formulation C
• DRUG: Dapsone 5% Gel

Sponsor

Allergan